Catalyst Wire Dossier Catalyst Wire Dossier

BI 44370 BS

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BI 44370 BS, covering 2014-08-13 to 2014-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Metabolism and Pharmacokinetics of [14C]-BI 44370 BS Administered as an Oral Solution in Healthy Male Volunteers [Phase 1]

See pricing